60 DEGREES PHARMACEUTICALS, INC. (SXTP) Form 10-Q — May 15, 2026
60 Degrees Pharmaceuticals reported a net loss of $2.09 million for the first quarter of 2026, driven by operating expenses of $2.17 million against net revenue of $76,377. The company raised approximately $3.37 million in net proceeds through its At-The-Market (ATM) offering during the quarter, bringing its cash position to $3.34 million. The filing includes a going concern warning, stating that the company does not have sufficient cash to fund its operating plan for the next 12 months and estimates its current cash runway extends only to mid-September 2026.
Key figures
- Revenue
- 76377
- Total Debt
- 150030
- Total Assets
- 6763346
- Cash Position
- 3337760
- Shares Outstanding
- 2659288
- Runway estimate
- mid-September 2026
- Atm net proceeds q1
- 3369752
- Reverse split ratio
- 1:4
- Derivative liability fair value
- 379308
Price after filing
Close on the filing date to close N calendar days later (from $1.46). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.